OverT Bio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $120K

  • Investors
  • 11

OverT Bio General Information

Description

Operator of a biotech company intended to provide cell therapy for cancers. The company's cell therapies identify and develop novel genetic modifications that help immune cells overcome barriers created by tumors and lead to effective and durable immunotherapies, enabling the healthcare industry to identify and cure cancer.

Contact Information

Website
www.overt.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 430 East 29th Street
  • 14 floor
  • New York, NY 10016
  • United States
+1 (646)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 430 East 29th Street
  • 14 floor
  • New York, NY 10016
  • United States
+1 (646)

OverT Bio Timeline

202320242025
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OverT Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 22-Nov-2024 $120K Completed Clinical Trials - General
3. Seed Round 06-May-2024 Completed Clinical Trials - General
2. Seed Round $8M $12.5M Completed Clinical Trials - General
1. Seed Round 04-Apr-2023 $4.49M $4.49M Completed Clinical Trials - General
To view OverT Bio’s complete valuation and funding history, request access »

OverT Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
To view OverT Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

OverT Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotech company intended to provide cell therapy for cancers. The company's cell therapies identify and de
Drug Discovery
New York, NY
10 As of 2024

Miami, FL
 

Gaithersburg, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OverT Bio Competitors (3)

One of OverT Bio’s 3 competitors is Longeveron, a Formerly VC-backed company based in Miami, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Longeveron Formerly VC-backed Miami, FL
Arcellx Formerly VC-backed Gaithersburg, MD
Chimeric Therapeutics Formerly VC-backed Carlton South, Australia
You’re viewing 3 of 3 competitors. Get the full list »

OverT Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OverT Bio Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
ScaleReady Corporation
Alexandria Venture Investments Venture Capital Minority
ARTIS Ventures Venture Capital Minority
Cancer Research Institute Limited Partner Minority
Civilization Ventures Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

OverT Bio FAQs

  • When was OverT Bio founded?

    OverT Bio was founded in 2022.

  • Where is OverT Bio headquartered?

    OverT Bio is headquartered in New York, NY.

  • What is the size of OverT Bio?

    OverT Bio has 10 total employees.

  • What industry is OverT Bio in?

    OverT Bio’s primary industry is Drug Discovery.

  • Is OverT Bio a private or public company?

    OverT Bio is a Private company.

  • What is OverT Bio’s current revenue?

    The current revenue for OverT Bio is .

  • How much funding has OverT Bio raised over time?

    OverT Bio has raised $28.5M.

  • Who are OverT Bio’s investors?

    ScaleReady, Alexandria Venture Investments, ARTIS Ventures, Cancer Research Institute, and Civilization Ventures are 5 of 11 investors who have invested in OverT Bio.

  • Who are OverT Bio’s competitors?

    Longeveron, Arcellx, and Chimeric Therapeutics are competitors of OverT Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »